How Safe Is Your Money In Reckitt Benckiser Plc?

Can Reckitt Benckiser Plc (LON:RB) afford a $14bn acquisition?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Consumer goods giant Reckitt Benckiser (LSE: RB) is in the headlines, after the firm admitted it is bidding to buy the consumer health arm of pharmaceutical firm Merck & Co, for a rumoured $14 billion.

One key question for Reckitt shareholders is whether their firm can afford the Merck deal — and whether shareholder returns are likely to suffer as a result.

reckitt.benckiserI’ve used three measures commonly used by credit rating agencies to take a closer look at Reckitt’s finances.

Passive income stocks: our picks

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

1. Interest cover

What we’re looking for here is a ratio of at least 2, to show that Reckitt’s earnings cover its interest payments with room to spare:

Operating profit /net interest costs

£2,345m / £24m = 97 times cover

Reckitt’s finance costs are low, and this, combined with its high profit margins, mean that interest cover is an exceptionally strong 97 times. An increase in debt — as is likely if the Merck deal goes ahead — shouldn’t be a problem for shareholders.

2. Gearing

Gearing is simply the ratio of debt to shareholder equity, or book value. I tend to use net debt, as companies often maintain large cash balances that can be used to reduce debt if necessary.

At the end of 2013, Reckitt reported net debt of £1,959m and equity of £6,336m, giving net gearing of 31%. This is well below my personal preferred maximum of 50%, but it’s clear that $14bn would be a big chunk of cash for Reckitt to find. However, one possible source of funds for Reckitt is its pharmaceutical division, which the firm is considering selling.

3. Operating margin

Reckitt reported an operating margin of 23.3% in 2013, down from 25.5% in 2012, due to exchange rate fluctuations.

Reckitt’s high profit margins generated £1.5bn of free cash flow in 2013, covering the firm’s dividend payment by 1.5 times, and allowing Reckitt to reduce its net debt by more than £500m.

Buy, hold or sell Reckitt?

Reckitt’s share price has risen by 83% over the last five years, rewarding long-term shareholders. However, for new buyers, the shares aren’t cheap, trading close to their 52-week high on a P/E of 18.5, with a prospective yield of just 2.8%.

Reckitt’s goal of becoming a dominant player in the consumer healthcare market offers strong growth potential, but a deal of this size is always risky. In my view, existing shareholders should sit tight, but for new buyers, there’s no need to rush in.

However, don’t buy any shares just yet

Because my colleague Mark Rogers – The Motley Fool UK’s Director of Investing – has released this special report.

It’s called ‘5 Stocks for Trying to Build Wealth After 50’.

And it’s yours, free.

Of course, the decade ahead looks hazardous. What with inflation recently hitting 40-year highs, a ‘cost of living crisis’ and threat of a new Cold War, knowing where to invest has never been trickier.

And yet, despite the UK stock market recently hitting a new all-time high, Mark and his team think many shares still trade at a substantial discount, offering savvy investors plenty of potential opportunities to strike.

That’s why now could be an ideal time to secure this valuable investment research.

Mark’s ‘Foolish’ analysts have scoured the markets low and high.

This special report reveals 5 of his favourite long-term ‘Buys’.

Please, don’t make any big decisions before seeing them.

Secure your FREE copy

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland does not own shares in any of the companies mentioned in this article.

More on Investing Articles

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

I bought 1,779 Legal & General shares 2 years ago – see how much dividend income I’ve got since

Harvey Jones holds Legal & General shares and has been pretty underwhelmed by their performance so far. The dividend is…

Read more »

Middle-aged black male working at home desk
Investing Articles

Is the FTSE 100 set to soar? Here are 3 ways to aim to cash in

My outlook for the FTSE 100 is definitely brightening as we get deeper into 2025. How can we make the…

Read more »

Investing Articles

£10k invested in NatWest shares on the ‘Liberation Day’ dip is today worth…

Harvey Jones looks at how NatWest shares have been knocked off course during recent market turbulence, but are now bouncing…

Read more »

Tariffs and Global Economic Supply Chains
US Stock

£5,000 invested in Nvidia stock just before the tariff news is now worth…

Jon Smith talks through the erratic movements in Nvidia stock over the past six weeks and reveals where an investor…

Read more »

Business manager working at a pub doing the accountancy and some paperwork using a laptop computer
Investing Articles

3 high-yield passive income stocks to consider buying right now

These stocks with big dividend yields look very tempting. Passive income investors could do well to consider taking the plunge.

Read more »

Handsome young non-binary androgynous guy, wearing make up, chatting on his smartphone, carrying shopping bags.
Investing Articles

Is a motley collection of businesses holding back this FTSE 100 stock?

Andrew Mackie explains why he's remained loyal to this FTSE 100 stock despite several of its businesses continuing to struggle…

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

3 top growth stocks driving wealth in my Stocks and Shares ISA

Our writer shines a light on a trio of outperforming growth firms in his Stocks and Shares ISA portfolio. They're…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Here’s where analysts expect the Lloyds share price to be a year from now

The Lloyds share price has fared well so far in 2025. But with some big issues on the horizon, can…

Read more »